Cellectis SA (CLLS)
1.91
-0.07
(-3.54%)
USD |
NASDAQ |
Nov 14, 16:00
1.90
-0.01
(-0.52%)
After-Hours: 20:00
Cellectis Gross Profit (Annual): 0.018M for Dec. 31, 2023
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.018M |
| December 31, 2022 | 17.40M |
| December 31, 2021 | 28.50M |
| December 31, 2020 | 49.11M |
| December 31, 2019 | 3.798M |
| December 31, 2018 | 9.992M |
| December 31, 2017 | 22.57M |
| December 31, 2016 | 43.03M |
| December 31, 2015 | 53.12M |
| Date | Value |
|---|---|
| December 31, 2014 | 22.61M |
| December 31, 2013 | 6.656M |
| December 31, 2012 | 12.92M |
| December 31, 2011 | 17.47M |
| December 31, 2010 | 18.92M |
| December 31, 2009 | 12.45M |
| December 31, 2008 | 13.22M |
| December 31, 2007 | 2.624M |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
0.018M
Minimum
2023
49.11M
Maximum
2020
19.76M
Average
17.40M
Median
2022
Gross Profit (Annual) Benchmarks
| Genfit SA | 30.56M |
| Edap TMS SA | 26.43M |
| Adaptimmune Therapeutics PLC | -- |
| NuCana PLC | -- |
| TC BioPharm (Holdings) PLC | -- |